Autres langues Biotron Limited

Actions

BIT

AU000000BIT4

Marché Fermé - Australian S.E. Autres places de cotation 07:15:00 03/05/2024			Varia. 5j.	Varia. 1 janv.
0,054 ^AUD	0,00 %		-11,48 %	-44,33 %

05/04	Biotron atteint les objectifs principaux de son essai de phase 2 sur le VIH ; les actions font un bond de 25	MT
26/02	Biotron Limited annonce ses résultats pour le semestre clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Biotron Meets Primary Objectives of Phase Two HIV Trial; Shares Surge 25%	05/04
Biotron Limited Reports Earnings Results for the Half Year Ended December 31, 2023	26/02
Biotron Secures Nearly AU$2 Million R&D Tax Rebate in Fiscal 2023	08/02
Biotron Limited Reports Earnings Results for the Full Year Ended June 30, 2023	25/08/23
Biotron Completes Dosing Segment of Phase Two COVID-19 Clinical Trial	16/08/23
Biotron Secures Second Site for COVID-19 Trial	12/05/23
Biotron Begins Phase Two COVID-19 Trial for Antiviral Medication	04/05/23
Biotron Completes Phase 2 HIV-1 Trial for Antiviral Drug	09/03/23
Biotron Limited Announces Completion of Phase 2 HIV-1 Clinical Trials	09/03/23
Biotron Limited Reports Earnings Results for the Half Year Ended December 31, 2022	17/02/23
Biotron Receives $958,000 R&D Tax Rebate for Drug Development Programs	18/11/22
Biotron Raising $2.7 Million for Clinical Trials, Drug Development; Shares Fall 20%	27/10/22
Biotron Completes Enrollment for Phase 2 HIV Trial; Shares Jump 7%	04/10/22
Biotron Starts Human Trials of COVID-19 Antiviral Drug; Shares Jump 13%	14/09/22
Biotron Completes Enrollment for Phase 2 HIV Trial in Thailand	23/08/22
Biotron Limited Reports Earnings Results for the Full Year Ended June 30, 2022	19/08/22
Biotron Limited Auditor Raises 'Going Concern' Doubt	19/08/22
Nanomix Corporation Announces Distribution Agreement for the eLab System with Biotron Ltd. in Israel	21/07/22
Biotron Secures US FDA Guidance for COVID-19 Antiviral Drug	30/05/22
Biotron Limited Receives Positive U.S. Food and Drug Administrations Guidance for COVID-19 Clinical Program	30/05/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Biotron Limited

Actions

BIT

AU000000BIT4

Autres langues

Filtres